We are pleased to have recently partnered with
Astellas Pharma Inc.
In this partnership, the Drais executive team has setup
separate virtual companies: Tacurion Pharma, Inc., Telsar Pharma, Inc. and Seldar Pharma,
Inc. to house development projects acquired from Astellas.
Drais is actively pursuing expansion of our
partnerships in this new and exciting business model.
Dr. Donna Tempel